Background Bioactive compounds from plants (ie, Serenoa repens) are often used in
medicine in the treatment of several pathologies, among which benign prostatic hyperplasia …

Background The use of herbal medicine and alternative medicine is reported to be in up to
50% of prescriptions for benign prostate hyperplasia (BPH) in Europe, along with an …

Anti-androgens are an assorted group of drugs and compounds that reduce the levels or
activity of androgen hormones within the human body. Disease states in which this is …

In this double‐blind, randomized clinical trial, 36 healthy male volunteers were randomly
distributed into three groups (n= 12) that underwent a three‐step treatment. For four …

Among the vast variety of plant-derived phytochemicals, the group of carotenoids has
continuously been investigated in order to optimize their potential application in the area of …

Background Patients who undergo surgery appear to use dietary supplements significantly
more frequently than the general population. Because they contain pharmacologically active …

The sourcing of raw materials with low environmental impact, eg,“upcycled” ingredients from
short supply chains, has currently become necessary, and agri-food waste represents a very …

The prevalence of benign prostatic hyperplasia (BPH) markedly increases with age.
Phytotherapeutic approaches have been developed over time owing to the adverse side …

Phytochemical extracts are highly complex chemical mixtures. In the context of an increasing
demand for phytopharmaceuticals, assessment of the phytochemical equivalence of …

WS® 1541 is a phytopharmaceutical drug combination containing a lipophilic extract from
fruits of Sabal serrulata (WS® 1473) and an aqueous ethanolic extract from roots of Urtica …